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Abstract
Older adults with dementia care needs often visit primary care physicians (PCPs), but PCP
dementia care limitations are widely documented. This study tested the value of employing a nurse
practitioner (NP) with geropsychiatric expertise to augment PCP care for newly and recently
diagnosed patients and family caregivers. Twenty-one dyads received the NP intervention; 10
dyads were controls. Outcomes included patient neuropsychiatric symptom and quality of life
changes, and caregiver depression, burden, and self-efficacy changes. Intervention acceptability by
patients, caregivers, and PCPs was determined. No outcome differences were found; however, the
NP intervention was deemed highly satisfactory by all stakeholders. Patients experienced no
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significant cognitive decline during their 12-month study period, helping explain why outcomes
did not change. Given widespread acceptability, future tests of this PCP-enhancing intervention
should include patients with more progressive cognitive decline at study entry. NPs with
geropsychiatric expertise are ideal interventionists for this rapidly growing target population.
Dementia, an age-associated clinical syndrome characterized by irreversible loss or decline
in memory and other cognitive abilities, is a growing health problem due primarily to the
steady aging of the population. In 2013, an estimated 5.2 million Americans were diagnosed
with Alzheimer’s disease (AD), the most common cause of dementia. This figure is
projected to reach 7.1 million Americans 65 and older with AD by 2025, and 13.8 million by
2050 (Alzheimer’s Association, 2013). AD accounts for an estimated 60% to 80% of all
dementia; therefore, projected figures for the number of Americans with all types of
dementia combined are even higher (Alzheimer’s Association, 2013).
Pharmacotherapy is only modestly effective in addressing cognitive and behavioral
symptoms of dementia; therefore, active management of dementia involves careful
monitoring of symptoms, treatment of comorbidities, medication monitoring,
nonpharmacological management strategies, and linkage to community support services
(Brodaty & Arasaratnam, 2012; Gitlin, 2012). Moreover, it has long been known that family
members caring for individuals with dementia often experience adverse health consequences
due to stresses associated with dementia symptoms and uncertainties about how to find
information and help to support their care responsibilities (Schulz & Beach, 1999; Schulz,
O’Brien, Bookwala, & Fleissner, 1995). Therefore, family members must be included in
active management of patients with dementia to maximize health-related outcomes for
patients and their family caregivers.
Many studies have demonstrated gaps in care provided by primary care physicians (PCPs) to
older adults with dementia in the United States and elsewhere (Callahan, Hendrie, &
Tierney, 1995; Fortinsky, 1998; Fortinsky, Leighton, & Wasson, 1995; Koch & Iliffe, 2010).
Considering the current U.S. health policy climate focused on improving health care quality
while reducing costs to Medicare and other health insurers, primary care enhancements that
could effectively address PCP gaps in care for patients with dementia hold great potential
for significant cost savings and improved health-related outcomes. A limited number of
published trials of nonpharmacological interventions to enhance primary care for people
with dementia and/or their family caregivers by augmenting the care provided by PCPs have
yielded positive results (Bass, Clark, Looman, McCarthy, & Eckert, 2003; Callahan et al.,
2006; Fortinsky, Kulldorff, Kleppinger, & Kenyon-Pesce, 2009; Maslow, 2012; Vickrey et
al., 2006). However, none have been successfully sustained beyond the study period or
replicated in community-based primary care settings. Tested interventions either required
unsustainable linkages between PCPs and community organizations, involved
multidisciplinary teams whose services are not presently reimbursable by Medicare or other
health insurers, or occurred solely at academic health centers where only a fraction of all
patients seek primary care. Therefore, models based on evidence-based care protocols still
need to be tested in community-based settings where most primary care is delivered in the
United States.
Fortinsky et al. Page 2
Res Gerontol Nurs. Author manuscript; available in PMC 2014 June 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Nurse practitioners (NPs) working collaboratively with PCPs successfully implemented
dementia care protocols in two published trials based at academic health centers (Callahan et
al., 2006; Vickrey et al., 2006). Although the scope of practice of NPs varies across the
United States, all NPs can diagnose, treat, and prescribe medications with physician
involvement (Iglehart, 2013). NP services provided in primary care settings, or in home
settings when approved by PCPs, are reimbursable by Medicare and many private health
insurance plans. Using NPs as primary care–based dementia care specialists is a timely
innovation given the growing recognition of roles NPs can play to address primary care
workforce shortages (Cassidy, 2012; Donelan, DesRoches, Dittus, & Buerhaus, 2013;
Iglehart, 2013) and the growing movement within the nursing profession to teach
geropsychiatry core competencies to new and established nurses and NPs due to the growing
older population living with dementia and other mental health–related challenges
(Buckwalter, 2005; Evans, Beck, & Buckwalter, 2012). Employing NPs as dementia care
experts in primary care settings is also consistent with many goals and strategies included in
the 2013 update to the National Alzheimer’s Project Act of 2011 (U.S. Department of
Health and Human Services [USDHHS], 2013) and with collaborative care and
comanagement principles that have been successfully tested to treat depression and other
geriatric conditions in the primary care setting (Reuben et al., 2013; Unützer, et al, 2002).
Accordingly, the current study implemented and evaluated an evidence-based NP-guided
dementia care intervention, where the NP received referrals from and worked
collaboratively with three community-based PCP group practice sites. Important differences
between this intervention and collaborative care models tested elsewhere are the home-based
location of NP-guided dementia care and the equal focus on the patient and family caregiver.
Targeted groups were individuals with newly or recently diagnosed AD or other dementia
(patients) and their family caregivers. This 12-month dementia care intervention, featuring
monthly in-home visits by the NP, used medication management and nonpharmacological
treatment protocols developed in a published randomized controlled trial that was tested at
an academic health center (Callahan et al., 2006). The intervention tested in this study was
called Proactive Primary Dementia Care (PPDC). The following two objectives, as well as
major hypotheses for Objective 1, formed the scope of this study:
• Objective 1: Determine the preliminary efficacy of PPDC on health-related
outcomes in patients and their family caregivers.
Patient-specific hypotheses: Patients receiving PPDC will show reduced or more
stabilized neuropsychiatric symptoms, as well as improved or more stabilized self-
reported quality of life, as compared to control group patients.
Family caregiver-specific hypotheses: Caregivers receiving PPDC will show
reduced or more stabilized depressive symptoms and burden, as well as increased
or more stabilized self-efficacy for managing dementia, as compared to control
group caregivers.
• Objective 2: Determine the acceptability of PPDC based on satisfaction expressed
by physicians, patients, and caregivers.
Fortinsky et al. Page 3
Res Gerontol Nurs. Author manuscript; available in PMC 2014 June 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
METHOD
Design and Setting
A nonequivalent control group design was used. For both intervention and control groups,
patient and family caregiver outcome measures were collected via in-person interviews at
three time points—immediately after obtaining written consent (baseline); 6 months later;
and 12 months after baseline. Primary endpoints were 12 months after baseline,
corresponding closely to the end of the PPDC intervention period. All data collected by
research interviewers were submitted to the study data manager on precoded forms ready for
automated scanning; scanned data were imported into Microsoft® Access files and prepared
for analysis by the study data manager. Research interviewers and the study data manager all
were trained by the first author (R.H.F.) in the data collection and processing protocols and
procedures followed in this study. All study procedures were reviewed and approved by the
Institutional Review Board at the first author’s institution.
The study was designed as a practice-based research partnership between the investigative
team and a large PCP network in a northeastern state in the United States. Three practice
sites within this large PCP network agreed to serve as intervention sites by incorporating the
NP-guided dementia care intervention into their group practices. Three other practice sites,
also part of the same large PCP network, originally agreed to serve as control sites; however,
one of these control sites withdrew due to competing clinical initiatives and was replaced
with a university-affiliated geriatrics primary care group.
During the PPDC intervention, control group patients and family caregivers received usual
care from their PCPs. Control group dyads also received educational pamphlets and
brochures published by the national Alzheimer’s Association explaining common dementia-
related symptoms and sources of caregiver stress, as well as pamphlets listing locally
available community resources. Research interviewers, trained by the first author,
distributed and reviewed these educational materials in detail with control group dyads
following completion of in-person baseline interviews. Control group dyads were instructed
by research interviewers to educate themselves about dementia and to contact community
resources as they saw fit. Following the 6-month follow-up interview with control group
dyads, research interviewers offered to review these educational materials again, answered
questions prompted by the brochures, and replaced brochures if they had been misplaced by
control group dyads.
Study Entry Criteria
Patient inclusion criteria were: (a) age 50 or older; (b) living at home; (c) English speaking;
(d) willing to participate in study per protocol; and (e) diagnosis of irreversible dementia
<12 months prior to the start of the study recruitment period, or newly diagnosed during the
recruitment period as evidenced by any of the following International Classification of
Diseases, ninth revision (ICD-9; World Health Organization, 1978) codes: arteriosclerotic
dementia (290.40–290.43); senile dementia (290.00–290.30); presenile dementia (290.10–
290.13); memory loss, mild (310.10); or Alzheimer’s disease (331.00). By selecting patients
who had been diagnosed with dementia <12 months prior to study recruitment startup, a
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reasonable balance was maintained between minimizing the length of time between
diagnosis and study entry and maximizing the expected number of patients satisfying all
study entry criteria.
Patient exclusion criteria were: (a) Mini-Mental State Examination (MMSE; Folstein,
Folstein, & McHugh, 1975) score <12; (b) dementia due to alcohol abuse or HIV/AIDS; (c)
any comorbid illness deemed terminal by PCP; and (d) living in a nursing home or assisted
living facility. The required minimum MMSE score was based on findings that patients
scoring ≥13 can respond consistently and accurately to questions about their demographic
characteristics and their daily care preferences (Feinberg & Whitlatch, 2001; Whitlatch,
Feinberg, & Tucke, 2005).
Family caregiver inclusion criteria were: (a) family member or significant other of eligible
patient, (b) English speaking, and (c) willing to participate in study per protocol. In most
cases, family caregivers deemed eligible by the first criterion were listed as the primary
contact in patients’ PCP medical records and routinely accompanied patients to PCP office
visits. No exclusion criteria were prespecified for family caregivers.
Participant Recruitment and Consent Procedures
Newly diagnosed patients during the recruitment period and family members accompanying
them to office visits were told about the study by PCPs. At this time, patients and caregivers
either gave PCPs permission to provide their contact information to research interviewers, or
they were given a study flyer with instructions on how to contact a research interviewer to
learn more about the study. Patients diagnosed <12 months before the start of the
recruitment period were identified through PCP site electronic billing records, and PCPs
verified the diagnosis. PCP office staff then sent personalized study invitation letters to these
patients and individuals listed in the medical records as primary contacts. Intervention site
letters explained the opportunity to participate in a project testing the use of a nurse specially
trained in helping patients and families after a dementia diagnosis. Control site letters
explained the opportunity to participate in a project seeking to learn how patients and
families adjust after a dementia diagnosis and to receive educational materials. Research
interviewers trained by the first author screened interested patients and family members by
telephone for eligibility; for those eligible, in-home visits for consenting and baseline data
collection were scheduled. During in-home visits, patients were evaluated for capacity to
provide written consent, adapting procedures developed for other adult populations with
potential decisional impairment (Jeste et al., 2007). Consistent with the IRB-approved study
protocol, patients found incapable of providing written consent and their family caregivers
were excluded and provided educational materials received by control group dyads as
described; in these cases, the principal investigator (R.H.F.) sent a letter to the referring PCP
explaining that the patient could not provide written consent and could therefore not
participate in the study.
Theoretical Basis for the PPDC Intervention
The Progressively Lowered Stress Threshold (PLST, Hall & Buckwalter, 1987) theoretical
model was used to frame the PPDC intervention. The PLST model posits that individuals
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with dementia need environmental conditions modified as they experience progressive
cognitive decline so that cues can be more easily processed and are thus less stressful.
Symptoms of dementia are clustered into intellectual losses, affective or personality losses,
conative or planning losses, and PLST, an array of behaviors that emerge when
environmental demands exceed the individual’s ability to cope. Within this framework, six
principles of care are proposed to keep stress to a manageable level: (a) maximize safe
function by supporting losses in a prosthetic manner; (b) provide unconditional positive
regard; (c) use anxiety and avoidance to gauge activity and stimulation levels; (d) teach
caregivers to observe and listen to patients; (e) modify environments to support losses and
enhance safety; and (f) provide on-going education, support, care, and problem-solving
(Gerdner, Buckwalter, & Reed, 2002; Hall & Buckwalter, 1987; Smith, Hall, Gerdner, &
Buckwalter, 2006). In this study, these PLST model principles were incorporated into the
PPDC protocols that comprised the intervention. The rationale for initiating PPDC as close
as possible to the time of diagnosis was that diagnostic disclosure has been found to lead
patients and families to begin planning for the future (Bamford et al., 2004); therefore, the
time of diagnosis is a teachable moment. The proactive nature of PPDC lies in the use of a
NP readily prepared as a provider in the primary care setting at a key point in the dementia
journey for patients and families.
Synopsis of the PPDC Intervention
The interventionist NP (E.S.) had prior extensive clinical experience with adult patient
populations. Prior to starting work with study patients and family caregivers, this NP
received competency-driven training and was deemed certified in geropsychiatry via a
guided curriculum supervised by two internationally known academic nurse scholars and
researchers. The PPDC intervention was written into a manual by a member (C.D.) of the
investigative team with nursing intervention research experience, and the manual was
reviewed extensively with the NP interventionist before subject recruitment began. Study
patient/family caregiver dyads were scheduled to be seen by the NP in the setting of their
choice (all chose in-home visits) for 12 in-person contacts over a 12-month period, including
two contacts in the first month, as outlined by the intervention protocol used in the
Alzheimer’s Collaborative Care study (Callahan et al., 2006). During the first two contacts,
the NP determined how well the dyad adjusted to the news of the dementia diagnosis and
explained the types of cognitive and behavioral symptoms that may be expected to develop
over time. A complete review of the patient’s current medications and clinical review of
systems was conducted, and any discovered medication side effects or potential interactions,
or other urgent signs and symptoms, were reported immediately to the referring PCP. The
NP did not initiate medication regimens but collaborated with the PCP to determine whether
drug therapy might be adjusted. Beginning with the third contact, and at every contact
thereafter, the Revised Memory and Behavior Problems Checklist (RMBPC; Teri et al.,
1992) was used as a guide to activate specific nonpharmacological protocols developed for
the Alzheimer’s Collaborative Care Study (Guerriero Austrom et al., 2004). The RMBPC
assesses the frequency of specific problems exhibited by the patient and how they affect the
caregiver. Nonpharmacological protocols implemented during the remaining intervention
contacts included: (a) stress management; (b) exercises for physical health; (c)
communication techniques; (d) legal and financial considerations; (e) depression and anxiety
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prevention, recognition, and management; (f) repetitive questioning and agitation; (g)
mobility management; (h) personal care concerns; and (i) paranoia, delusions, and
hallucinations. The NP sent secure electronic updates to referring PCPs after each
intervention contact, and if warranted, secure electronic correspondence ensued between the
NP and PCP.
To monitor treatment fidelity, selected procedures were used from a model from the
National Institutes of Health Behavior Change Consortium (Bellg et al., 2004). Procedures
included development and use of an intervention manual with standardized guidelines,
completion of a checklist by the NP at every contact to record intervention components
delivered, and quarterly conferences between the NP and members of the investigative team.
Measures
Patient Outcome Measures—The primary patient outcome was prevention or
alleviation of behavior and mood problems. This outcome was measured using the
Neuropsychiatric Inventory (NPI; Cummings et al., 1994), the same primary outcome used
in the Alzheimer’s Collaborative Care study (Callahan et al., 2006). The NPI uses an
interview format to solicit reports from an informant familiar with the patient’s behavior and
inquires about the frequency and severity of behavioral disturbances that commonly occur
throughout the course of dementia, including anxiety, agitation, apathy, irritability, aberrant
motor activity, euphoria, dysphoria, disinhibition, delusions, and hallucinations. The NPI is
scored such that higher scores represent greater symptoms. It has been estimated that a 1-
point decline in total NPI score is associated with an additional $250 to $400 annually in
direct health care costs (Murman & Colenda, 2005).
The secondary patient outcome was self-reported quality of life, using the Quality of Life-
Alzheimer’s Disease Scale (QOL-AD; Logsdon, Gibbons, McCurry, & Teri, 2002). The
rationale for using a patient-reported outcome measure was that the proposed intervention
was intended to involve the patient as an equal partner and because the effects of
interventions involving dyads on patient self-reported QOL are virtually unknown (Smits et
al., 2007). The QOL-AD consists of 13 items encompassing conceptual domains of QOL in
older adults; in an article reporting its psychometric properties, internal consistency
reliability for the QOL-AD was 0.84, and validity was established through expected
correlations with measures of depression and physical function (Logsdon et al., 2002).
Family Caregiver Measures—The primary outcome for study family caregivers was
prevention or alleviation of depressive symptoms over the 12-month study period. This
outcome was measured using the 20-item Center for Epidemiologic Studies-Depression
(CES-D) inventory (Radloff, 1977). Internal consistency reliability of this measure has been
consistently high, and strong evidence of convergence and discriminant validity has been
reported (Ostwald, Hepburn, Caron, Burns, & Mantell, 1999; Radloff, 1977).
The secondary family caregiver outcomes emphasized self-efficacy because this construct is
studied much less often than depression or other mental health outcomes in intervention
evaluations (Fortinsky, 2001; Smits et al., 2007). Two measures of family caregiver self-
efficacy for managing dementia were used: symptom management self-efficacy and
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community support service use self-efficacy. The symptom management self-efficacy
measure contains five items, and the community support service use self-efficacy measure
contains four items; each item has a response range from 1 (not at all certain) to 10
(completely certain). Internal consistency reliability for these two measures were found to be
0.77 and 0.78, respectively, and construct validity was established by finding positive
correlations between these two measures and a global caregiver competence scale, as well as
negative correlations between these measures and the CES-D (Fortinsky, Kercher, & Burant,
2002).
Caregiver burden served as the other secondary outcome for family caregivers. The 12-item
short form of the Zarit Burden Interview (ZBI) assesses caregivers’ subjective feelings about
effects of care provision on emotional, physical, social, and financial life domains. The short
form ZBI was shown to correlate very highly (0.92 to 0.97) with the full 22-item burden
inventory at two different time points and showed high internal consistency reliability (0.88)
(Bédard et al., 2001).
Acceptability Measures—Acceptability was evaluated by determining the level of
satisfaction with the intervention from the perspectives of physicians, patients, and family
caregivers. Based on discussions with intervention group PCPs before the start of the study
about how they would judge the acceptability of the PPDC, investigators constructed a self-
administered, patient-specific questionnaire for completion by PCPs when each patient
ended the intervention. This questionnaire included six items with Likert scale responses (1
to 4) ranging from very satisfied to very dissatisfied, each accompanied by a comment
section for PCPs to provide further explanations of their responses. PCPs were also asked
open-ended questions about their experiences with and opinions on how to refine the PPDC
intervention. PCPs completed these self-administered questionnaires and faxed or sent via e-
mail attachment their completed questionnaires to the study data manager (A.K.) trained by
the first author. A final debriefing session with intervention group PCPs was convened by
the first author to learn any final recommendations they had about how to optimize NP
involvement in their practice sites and with their patients going forward.
Patients and family caregivers also completed self-administered questionnaires inquiring
about their satisfaction with the intervention. The 12-item treatment satisfaction
questionnaire consisted of Likert scale responses (same responses as for PCP questionnaires)
to questions tailored specifically to the PPDC intervention process. Domains of satisfaction
—with the interventionist and with the content of the intervention material—were adapted
from measures of acceptability used in published studies on a dyadic intervention in early
stage dementia (Whitlatch, Judge, Zarit, & Femia, 2006) and a telephone intervention for
family caregivers of dementia patients (Tremont, Davis, Bishop, & Fortinsky, 2008).
Comments were solicited for each response, and two open-ended questions at the end
allowed further comments. This self-administered questionnaire was completed separately
by patients and caregivers following completion of the 12-month follow-up interview. The
research interviewer did not ask these satisfaction questions in an interview style; instead,
patients and family caregivers separately completed their own satisfaction questionnaires
without any input from the research interviewer. This approach maximized the capacity of
patients and caregivers to report on satisfaction independently and privately.
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Analysis
This study was originally designed to enroll a total of 70 patient-family caregiver dyads,
with 35 dyads in each study group. These samples would have resulted in 75% power to
detect an effect size in the patient NPI score (primary patient outcome) similar to the effect
size found in the Alzheimer’s Collaborative Care study (Callahan et al., 2006). We also
originally intended to use parametric statistics to analyze results. However, due to lower-
than-expected enrollment with resulting small samples, as well as non-normal distributions
of most outcome variables in our study samples, we chose to use nonparametric statistics
(Hollander & Wolfe, 1999) to analyze observed treatment group differences. Kruskal Wallis
nonparametric tests were used to determine significant differences in median scores within
each treatment group over time. To determine intervention effects, Freidman tests were used
to compare median differences between treatment groups adjusted for the three time points.
Statistical significance was defined as p < 0.05. SAS 9.1 was used for these analyses.
Intention-to treat-analyses were conducted for all models tested, with the assumption that
any missing data were randomly distributed across study participants.
RESULTS
Study Samples and Characteristics
A total of 31 dyads were enrolled in this study—21 dyads in the PPDC intervention group
and 10 dyads in the control group. The Figure provides a schematic view of study
participant recruitment, starting with the total number of dyads that received either
personalized PCP invitation letters to participate or direct referrals from PCPs to the
research team, both per study protocol, and ending with the number of patients and
caregivers who remained in the study through 12-month follow-up data collection.
Table 1 summarizes characteristics of the 31 study patients and their caregivers,
respectively, at the time of baseline data collection. As Table 1 shows, intervention and
control group patients did not differ significantly from one another in terms of
sociodemographic characteristics or cognitive status, the latter measured by the MMSE
(Folstein et al., 1975). Table 1 shows that intervention and control group caregivers did not
differ significantly from one another in terms of baseline sociodemographic characteristics.
PPDC Intervention Delivery Results
Of the 21 intervention group dyads, 16 (76.2%) dyads completed all 12 in-home sessions
with the NP per protocol. Among the non-completers, one dyad received nine visits and then
the NP was unsuccessful in reaching them at home; one dyad received eight visits and then
the patient was admitted to a nursing facility; one dyad received four visits and then chose to
suspend visits and did not resume; one dyad received three visits and then the patient died;
and one dyad received no in-home visits because the patient was admitted to a nursing
facility before the first scheduled visit was made.
The mean length of all visits made to the 21 dyads was 1 hour 15 minutes (SD = 21 minutes,
range = 30 minutes to 3 hours, 45 minutes). Visits 1 and 2 lasted longer on average than the
Fortinsky et al. Page 9
Res Gerontol Nurs. Author manuscript; available in PMC 2014 June 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
remaining sessions, with mean lengths of 1 hour 51 minutes and 1 hour 38 minutes,
respectively.
PPDC Efficacy Analysis Results
Table 2 summarizes all outcome measures related to specific hypotheses associated with
study Objective 1. Patient outcomes were the NPI score and QOL-AD score, whereas family
caregiver outcomes were depressive symptoms, burden, and dementia management self-
efficacy scores. Kruskal Wallis test results show that neither treatment group of patients or
caregivers experienced statistically significant changes in any of the median outcome
measure scores over time (all values p > 0.05). Freidman test results show that there were no
statistically significant between-group differences in any of the patient or family caregiver
outcome measures after adjusting for the three time points (all values p > 0.05).
Acceptability Analysis Results
Table 3 summarizes results of satisfaction surveys completed by intervention group patients
and family caregivers, and Table 4 summarizes results of satisfaction surveys completed by
referring PCPs responsible for medical care for intervention group patients. Table 3 and
Table 4 show that there was an extremely high level of satisfaction expressed by patients,
caregivers, and PCPs participating in the PPDC intervention. Mean satisfaction scores for all
items for all respondent groups ranged from 3.5 to 4.0, where 4 was the highest level of
satisfaction on response scales. Table 3 indicates that all caregivers gave the highest rating
of satisfaction to the item asking about whether PPDC program material was relevant to
their situation, and patients gave highest satisfaction marks on the question of the
interventionist’s ability to help them feel better about the future. Table 4 shows that
participating PCPs were overwhelmingly satisfied with all aspects of the intervention. PCPs
were most satisfied with the PPDC intervention’s effect on patient mood and outlook when
patients made office visits during the study observation period. PCPs were slightly less
satisfied with the interventionist’s reporting of patients’ progress at monthly meetings.
Results from debriefing sessions with PCPs revealed that PCPs would have been even more
satisfied if they had had the opportunity to hold periodic meetings together with the NP
interventionist as well as the patient and family caregiver (results not shown).
DISCUSSION
Several study findings and experiences are noteworthy, particularly as they relate to
implications for future nursing research, nursing practice, and public policy related to
community-based care for individuals with dementia and their families. First, all
stakeholders—PCPs, patients, and caregivers—reported overwhelming satisfaction with the
PPDC care model, particularly the in-home care setting of care delivery.
These acceptability results strongly suggest that the NP-guided PPDC care model has
demonstrated proof of concept to the key model participants. One caution regarding these
results is that with a single interventionist, reported satisfaction might be due to personal
relationships between NP and stakeholders rather than the intervention itself; however,
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satisfaction items completed by patients, caregivers, and PCPs included items that focused
on NP skills as distinct from personality, and all of these items were rated highly as well.
Second, the PPDC intervention did not measurably improve patient or family caregiver
outcomes compared to those in the control group patients and caregivers. Although this
finding might be interpreted as a less-than-efficacious intervention, it is also possible that
outcomes did not change over time in either treatment group because during the 12-month
intervention period patients did not experience measurable cognitive decline. Specifically,
median MMSE scores for the 17 intervention group patients with complete follow-up data
declined very slightly from 26 to 24 between baseline and 12-month follow-up, whereas for
the 6 control group patients with complete follow-up data median MMSE scores declined by
only 1 point, from 26 to 25, over their follow- up period. Therefore, it is possible that little
change was observed across all patient and family caregiver outcome measures because the
severity of patients’ cognitive symptoms remained nearly stable over the study period. From
the perspective of the PLST model that guided the intervention, stress threshold levels were
not necessarily lowered during the 12-month observation period because patients’ cognitive
symptoms remained nearly stable.
The lesson from this finding is that patients with a more diverse dementia experience,
including those with more progressive dementia-related symptoms, should be studied in
future trials such as the PPDC. Additionally, future studies recruiting patients with relatively
mild cognitive decline at study baseline must allow for a longer follow-up period than 12
months to increase the likelihood that patients will experience cognitive decline, which is
often the trigger for development of neuropsychiatric symptoms in patients and increased
levels of burden and depressive symptoms as well as decreased self-efficacy levels in family
caregivers. A larger-scale trial would allow for a longer follow-up period to overcome this
important study limitation.
Closer inspection of median score patterns in Table 3 suggests the following trends:
Intervention group family caregivers had more depressive symptoms and higher burden
scores at baseline than control group caregivers; changes over time in NPI scores favored
control group patients; and symptom management self-efficacy score changes over time
favored control group caregivers. Observed trends in changes over time are in the opposite
direction than hypothesized, and they might be explained by intervention group caregivers
having greater baseline mental health symptoms than controls, along with an insufficiently
potent intervention to counteract these between-group differences in baseline caregiver
mental health.
Third, PCPs reported to the investigative team in a final debriefing session that, although
they were satisfied with the PPDC intervention content, they would prefer to work with NPs
who are fully employed in their practice sites. A key implication of this finding is that NPs
serving as dementia care specialists, or more broadly as geropsychiatric NPs, would more
quickly assume their role as a team member if recruited from the ranks of existing NPs
working within PCP sites and then trained to work with patients with dementia and their
families. More broadly, the collaborative care and comanagement principles and models on
which this study is based (Callahan et al., 2006; Reuben et al., 2013; Unützer et al., 2002)
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would appear to be highly acceptable to PCPs in this study if the PPDC model is refined to
combine office and home visiting for longer-term clinical oversight of patients with
dementia and their families.
Fourth, PCPs reported in the final debriefing session that they believed the PPDC
intervention could be equally effective in a much shorter time period than 12 months. They
suggested that a 4-month intervention in which the first two visits retained focus on
complete review of medications and systems for signs of additional comorbidities, and in
which the remaining visits focused on teaching patients and families about how to prepare
for the future given the course of dementia diseases, stood a much greater chance of being
reimbursable by Medicare and other insurers. These refinements might lead to a more
financially sustainable model of NP-guided dementia care as an extension of customary
primary care.
Finally, major unanticipated challenges hampered recruitment success for this study,
yielding an under-powered study because only 31 dyads were enrolled compared to the
originally expected 70 dyads on which power estimates were based. The PCP practice
network that had agreed to supply intervention and control group sites for this study made a
critical business decision (i.e., to implement steps necessary to achieve patient-centered
medical home [PCMH] status) coincident with the study period. Achieving PCMH status, an
important goal for many physician groups in the current health care policy climate in the
United States, involved a tremendous amount of site reengineering at participating PCP sites
and other network sites, including purchase and implementation of and complete conversion
to electronic health records and development of associated meaningful use activities. These
PCMH accreditation-related activities led to considerable office flow changes as well.
Control group sites that had originally agreed to participate in this study withdrew due to the
overwhelming requirements associated with PCMH-related activities. Intervention sites that
agreed to participate in the study remained committed; however, the amount of time
available to office staff to assist with recruitment was significantly reduced due to priority
placed on PCMH-related activities. In July 2011, this PCP network achieved Level III
PCMH accreditation from the National Center for Quality Assurance for all 80 of its
practice sites. More recently, in January 2013, this PCP network achieved Medicare Shared
Savings Accountable Care Organization approval from the Centers for Medicare and
Medicaid Services. This achievement bodes well for future studies involving creative uses of
NPs within this and other PCP networks, including a larger-scale trial of a refined PPDC
intervention.
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Figure.
Flow chart of study participant recruitment.
Note. CG = caregiver.
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TABLE 1
Baseline Characteristics of Study Patients and Family Caregivers
Characteristic Intervention Group (n = 21) Control Group (n = 10) Total (N = 31) p Value
Patients
Female (%) 62 40 55 0.25
Age (mean, SD) (years) 76.9 (7.8) 80.7 (9.6) 78.1 (8.4) 0.25
Race (%) 0.55
 Caucasian 95 90 94
 African American 5 10 6
Educational level (%) 0.73
 Less than high school 10 0 6
 High school only 48 40 45
 Some college 14 10 13
 College graduate 29 50 36
Lives with caregiver (%) 95 80 90 0.24
Married (%) 76 60 71 0.35
MMSE score, mean (SD) 24.1 (5.5) 25.1 (2.3) 24.4 (4.7) 0.46
Family caregivers
Female (%) 48 70 55 0.24
Age (mean, SD) (years) 67.4 (13.8) 69.9 (14.9) 68.2 (14) 0.65
Race (%) 0.97
 Caucasian 91 90 90
 African American 9 10 10
Educational level (%) 0.17
 Less than high school 5 0 3
 High school only 33 10 26
 Some college 33 20 29
 College graduate 29 70 42
Relation to patient (%) 0.75
 Spouse 71 70 71
 Adult child 19 30 23
 Other relative 10 0 6
Married (%) 95 90 94 0.58
Annual income (%) 0.45
 <$40,000 19 10 16
 $40,000 to $49,999 19 10 16
 ≥$50,000 52 70 58
 Refused to answer 10 10 10
Note. MMSE = Mini-Mental State Examination (Folstein, Folstein, & McHugh, 1975). Percentages may not total 100 due to rounding.
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TABLE 3
Patient and Family Caregiver Satisfaction with the Proactive Primary Dementia Care (PPDC) Program
n (Mean Scorea, SD)
Satisfaction Measure Patients Caregivers
Nurse practitioner (NP) sensitivity to your concerns 14 (3.9, 0.3) 19 (3.9, 0.2)
NP ability to answer your questions 13 (4) 19 (4)
NP enthusiasm about working with you 14 (4) 19 (4)
NP ability to help you feel better about facing the future 13 (4) 19 (3.9, 0.3)
NP ability to link you with community resources 11 (3.8, 0.4) 19 (3.9, 0.3)
Overall satisfaction with NP 13 (4) 19 (4)
PPDC program material relevance to your situation 10 (3.8, 0.4) 18 (4)
Quality of discussion of material 12 (3.8, 0.4) 19 (4)
Quality of dyad discussions between NP meetings 11 (3.7, 0.7) 19 (3.5, 0.7)
Amount of information learned on how to plan for the future 12 (3.6, 0.9) 19 (3.9, 0.2)
Amount of information learned about community resources 12 (3.5, 0.9) 19 (3.9, 0.5)
Overall program satisfaction 13 (3.9, 0.4) 19 (3.9, 0.3)
aSatisfaction measure scores range from 1 (very dissatisfied) to 4 (very satisfied).
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TABLE 4
Primary Care Physician Satisfaction with the Nurse Practitioner’s Care
Satisfaction Measure na Mean Scoreb (SD)
Monitoring the patient’s medication for dementia symptoms 18 3.8 (0.4)
Monitoring the status of any comorbidities and related symptoms 18 3.8 (0.4)
Reporting on the patient’s progress at monthly meetings 18 3.7 (0.7)
Having an effect on the mood and outlook of the patient based on office visits during the year 16 4.0 (0.0)
Saving you time during the year in taking care of the patient’s dementia-related problems 16 3.8 (0.4)
Your overall satisfaction with the PPDC intervention 18 3.8 (0.4)
Note. PPDC = proactive primary dementia care.
a
n refers to the number of patients whose care by the nurse practitioner was rated by the eight participating intervention group primary care
physicians.
bSatisfaction measure scores range from 1 (very dissatisfied) to 4 (very satisfied).
Res Gerontol Nurs. Author manuscript; available in PMC 2014 June 01.
